NDC 83257-001
Ogivri 150 mg per 7.4 mL injection, powder, lyophilized, for solution
On the label: Biocon Biologics Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Biocon Biologics Limited | Bengaluru, India | Makes it, tests it and packages it | Problems found, fixed voluntarilyJul 26, 2024 · 11 inspections, 1 with FDA action |
Product details
- Generic drug
- Trastuzumab: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 150 mg per 7.4 mL
- Approval
- BLA BLA761074
- On the market since
- Oct 1, 2023
- Package NDCs
83257-001-11- Official label
- DailyMed (National Library of Medicine), updated Jun 26, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?